par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementRoka BioScience, Inc. • October 30th, 2015 • Laboratory analytical instruments • New York
Company FiledOctober 30th, 2015 Industry JurisdictionRoka Bioscience, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: